Julius Baer Group Ltd.:戦略・SWOT・企業財務分析

◆英語タイトル:Julius Baer Group Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015535
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:金融サービス
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Julius Baer Group Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

Julius Baer Group Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Julius Baer Group Ltd. (Julius Baer) is a Swiss private banking group. The company and its subsidiaries offer private banking and asset management services to high-net-worth individuals (HNWIs have a net worth of US$1 million or more, excluding their primary residence) and institutional clients, independent asset managers and fund distribution partners. Its product portfolio includes advisory services, wealth management services, tax planning, estate planning, investment funds, mandates and structured products. Services offered by the company include private labeling, global custody, research, securities trading, foreign exchange trading, and online services. Major operating company of Julius Baer is Bank Julius Baer & Co. Ltd (Bank Julius Baer). Bank Julius Baer has a presence in all the major financial centers. Julius Baer is headquartered in Zurich, Switzerland.

Scope

- Detailed information on Julius Baer Group Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Julius Baer Group Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Julius Baer Group Ltd. including a breakdown and examination of key business segments
- Intelligence on Julius Baer Group Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Julius Baer Group Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Julius Baer Group Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Julius Baer Group Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Julius Baer Group Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Julius Baer Group Ltd.: Company Overview
Julius Baer Group Ltd.: Overview and Key Facts
Julius Baer Group Ltd.: Overview
Julius Baer Group Ltd.: Key Facts
Julius Baer Group Ltd.: Key Employees
Julius Baer Group Ltd.: Key Employee Biographies
Julius Baer Group Ltd.: Major Products and Services
Julius Baer Group Ltd.: Company History
Julius Baer Group Ltd.: Management Statement
Julius Baer Group Ltd.: Locations and Subsidiaries
Julius Baer Group Ltd.: Key Competitors
Julius Baer Group Ltd.: Company Analysis
Julius Baer Group Ltd.: Business Description
Julius Baer Group Ltd.: SWOT Analysis
Julius Baer Group Ltd.: SWOT Overview
Julius Baer Group Ltd.: Strengths
Julius Baer Group Ltd.: Weaknesses
Julius Baer Group Ltd.: Opportunities
Julius Baer Group Ltd.: Threats
Julius Baer Group Ltd.: Corporate Financial Deals Activity
Julius Baer Group Ltd.: Financial Deals Overview
Julius Baer Group Ltd.: Targets and Partners
Julius Baer Group Ltd.: Top Deals 2013 – 2017YTD*
Julius Baer Group Ltd.: Mergers and Acquisitions
Julius Baer Group Ltd.: Corporate Venturing
Julius Baer Group Ltd.: Capital Raising
Julius Baer Group Ltd.: Divestments
Julius Baer Group Ltd.: Recent Developments
Julius Baer Group Ltd.: News and Events Summary
Julius Baer Group Ltd.: Business Expansion
Julius Baer Group Ltd.: Corporate Governance
Julius Baer Group Ltd.: Financial Performance
Julius Baer Group Ltd.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Julius Baer Group Ltd.: Key Facts
Table 2: Julius Baer Group Ltd.: Key Employees
Table 3: Julius Baer Group Ltd.: Locations and Subsidiaries
Table 4: Julius Baer Group Ltd.: Key Competitors
Table 5: Julius Baer Group Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Julius Baer Group Ltd.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: Julius Baer Group Ltd.: M&A Average Deal Size - Value (US$m)
Table 8: Julius Baer Group Ltd.: Targets and Partners
Table 9: Julius Baer Group Ltd.: Top Deals 2013 - 2017YTD*
Table 10: Julius Baer Group Ltd.: M&A Volume and Value Trend (2013 - YTD*2017)
Table 11: Julius Baer Group Ltd.: M&A Activity by Geography (2013 - YTD*2017)
Table 12: Julius Baer Group Ltd.: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 13: Julius Baer Group Ltd.: Corporate Venturing by Geography (2013 - YTD*2017)
Table 14: Julius Baer Group Ltd.: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 15: Julius Baer Group Ltd.: Capital Raising by Deal Type (2013 - YTD*2017)
Table 16: Julius Baer Group Ltd.: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 17: Julius Baer Group Ltd.: News and Events Summary
Table 18: Julius Baer Group Ltd.: Business Expansion
Table 19: Julius Baer Group Ltd.: Corporate Governance
Table 20: Julius Baer Group Ltd.: Financial Performance
Table 21: Julius Baer Group Ltd.: Strategy and Operations

★海外企業調査レポート[Julius Baer Group Ltd.:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eagle Cement Corporation (EAGLE):企業の財務・戦略的SWOT分析
    Eagle Cement Corporation (EAGLE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Rotork Plc (ROR):石油・ガス:M&Aディール及び事業提携情報
    Summary Rotork Plc (Rotork) is a manufacturer of actuator. The company’s key offerings include electric actuators, fluid power actuators, gearboxes, mounting kits and precision control instruments. The company also provides installation, maintenance and repair, field services, technical support and …
  • Sysco Corporation (SYY):企業の財務・戦略的SWOT分析
    Sysco Corporation (SYY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Otter Tail Corp (OTTR):企業の財務・戦略的SWOT分析
    Otter Tail Corp (OTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Catholic University of Leuven:医療機器:M&Aディール及び事業提携情報
    Summary Catholic University of Leuven (KU Leuven) is a scientific research and educational service provider that provides bachelors degree, post graduate degree and doctorate degree programs. The university provides educational courses in the areas of psychology and educational sciences, arts, law, …
  • Accelerate Diagnostics Inc (AXDX):医療機器:M&Aディール及び事業提携情報
    Summary Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company that undertakes the development and commercialization of instrumentation for identification and testing the antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, in …
  • Crescita Therapeutics Inc (CTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Crescita Therapeutics Inc (Crescita Therapeutics) is a commercial dermatology company that offers prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. The company’s products comprise Pliaglis, Alyria, Laboratoire Dr Renaud, Pro-Derm, Premi …
  • Novo Nordisk A/S:戦略・SWOT・企業財務分析
    Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report Summary Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • BioDelivery Sciences International Inc (BDSI):企業の財務・戦略的SWOT分析
    BioDelivery Sciences International Inc (BDSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Par Pacific Holdings Inc (PARR):石油・ガス:M&Aディール及び事業提携情報
    Summary Par Pacific Holdings Inc (Par Pacific), formerly known as Par Petroleum Corporation, manages, owns and maintains interests in energy and infrastructure related businesses. It has operations across the value chain from natural gas production to distribution and transportation. The company con …
  • Shell Pakistan Ltd (SHEL):企業の財務・戦略的SWOT分析
    Summary Shell Pakistan Ltd (Shell Pakistan), a subsidiary of Royal Dutch Shell plc is an oil and gas company that markets petroleum products and compressed natural gas. The company operates through three segments such as retail, lubricants and aviation. It retail segment offers a range of fuels such …
  • The Bank of Yokohama, Ltd.:企業の戦略・SWOT・財務情報
    The Bank of Yokohama, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Bank of Yokohama, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • DASAN ZHONE SOLUTIONS, INC.:企業の戦略・SWOT・財務情報
    DASAN ZHONE SOLUTIONS, INC. - Strategy, SWOT and Corporate Finance Report Summary DASAN ZHONE SOLUTIONS, INC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cisco Systems, Inc.:企業の戦略・SWOT・財務情報
    Cisco Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cisco Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Natus Medical Incorporated (BABY)-医療機器分野:企業M&A・提携分析
    Summary Natus Medical Incorporated (Natus) is a provider of newborn and neurology healthcare products. Its offers wide range of products for the screening, diagnosis, detection, treatment, monitoring and tracking of ailments in newborn. Natus also offers products for diagnostic hearing assessment in …
  • Enercon Services Inc-エネルギー分野:企業M&A・提携分析
    Summary Enercon Services, Inc. (Enercon) is a diversified consulting company offering architectural engineering, environmental, technical and management services. Its offerings include licensing, operations, permitting, construction, decommissioning, and staff augmentation, cyber security and regula …
  • Bluefish Pharmaceuticals AB-製薬・医療分野:企業M&A・提携分析
    Summary Bluefish Pharmaceuticals AB (Bluefish Pharmaceuticals) is a manufacturer and distributor of generic pharmaceutical products. The company provides products for various therapeutic areas including cardiovascular, the central nervous system, gastrointestinal, diabetes, oncology, dermatology, re …
  • Ramky Infrastructure Limited:企業の戦略・SWOT・財務情報
    Ramky Infrastructure Limited - Strategy, SWOT and Corporate Finance Report Summary Ramky Infrastructure Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • T2 Biosystems Inc (TTOO):企業の財務・戦略的SWOT分析
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. T2 Biosystems offers T2HemoSta …
  • Mutuelle Generale de l’Education Nationale:企業の戦略的SWOT分析
    Mutuelle Generale de l'Education Nationale - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆